(1)
A Sensitive Bioanalytical Method Development and Validation of Cabozantinib in Human Plasma by LC-ESI-MS MS. Braz. J. Pharm. Sci. 2018, 54 (2), e17163. https://doi.org/10.1590/s2175-97902018000217163.